Cargando…
Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
To evaluate the efficacy of cisplatin, gemcitabine, and treosulfan (CGT) in 91 patients with pretreated relapsed AJCC stage IV cutaneous malignant melanoma. Patients in relapse after first-, second-, or third-line therapy received 40 mg m(−2) intravenous (i.v.) cisplatin, 1000 mg m(−2) i.v. gemcitab...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360238/ https://www.ncbi.nlm.nih.gov/pubmed/17971774 http://dx.doi.org/10.1038/sj.bjc.6604045 |